tranScrip is a leading contract drug development organisation which supports the development and lifecycle of medicines, medical devices and combination products.

Identify and assess potential investee companies and products, and manage the development of acquired assets with focus on clinical development

Celtic Pharma is a private equity fund investing in the pharmaceutical drug development. Value is created by investing early and using the expertise of employees to develop the drug product to provision of key data that adds significant value.

Executive Team member for Merck Ethical Pharma responsible for instituting a new Portfolio management process and cross-functional management of all development projects through chairing Product Development Committee. Line management of all Project Leaders, Project Managers, Portfolio Management Group and Commercial Services (approx: 100 personnel).Moved on from Merck when merger with Serono resulted in very different senior managment structure.

Member of Oncology and Infection Therapy Area Management Team responsible for leading creation of strategy and ensuring implementation

Lead cross-functional strategy development and delivery of Oncology products, including IRESSA to regulatory approval and launch in Japan and USA

Manager of clinical project leaders across a variety of therapy areas. Previously clinical project leader for Accolate Phase IIIb programme in asthma.

Cross-functional operational project management of a variety of drug projects in the asthma and inflammation therapy areas.

Head of research laboratory focusing on protein characterisation supporting a number of drug reseach and development projects